Cargando…

Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?

The polygenic nature of neurological and psychiatric syndromes and the significant impact of environmental factors on the underlying developmental, homeostatic, and neuroplastic mechanisms suggest that an efficient therapy for these disorders should be a complex one. Pharmacological interventions wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gladkova, Marina G., Leidmaa, Este, Anderzhanova, Elmira A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253154/ https://www.ncbi.nlm.nih.gov/pubmed/37296584 http://dx.doi.org/10.3390/cells12111464

Ejemplares similares

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
por: Kim, Ayoung, et al.
Publicado: (2023)

Epidrugs: Toward Understanding and Treating Diverse Diseases
por: Umehara, Takashi
Publicado: (2022)

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
por: Montalvo-Casimiro, Michel, et al.
Publicado: (2020)

Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
por: Ashraf, Waseem, et al.
Publicado: (2023)

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
por: Ramírez-Alarcón, Karina, et al.
Publicado: (2021)

Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer
por: Guerra, Joaquín, et al.
Publicado: (2021)

Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
por: Abdullah, Omeima, et al.
Publicado: (2021)

Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience
por: Anderzhanova, Elmira, et al.
Publicado: (2017)

Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
por: Ghorbaninejad, Mahsa, et al.
Publicado: (2020)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Extracellular vesicle therapy for traumatic central nervous system disorders
por: Zhang, Jing, et al.
Publicado: (2022)

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
por: de Guillebon, E., et al.
Publicado: (2021)

Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders?
por: Stepan, Jens, et al.
Publicado: (2018)

Zinc and Central Nervous System Disorders
por: Wang, Bangqi, et al.
Publicado: (2023)

HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs
por: Shah, Sanket G., et al.
Publicado: (2020)

Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease
por: Ghosh, Asish K.
Publicado: (2021)

The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
por: Bouyahya, Abdelhakim, et al.
Publicado: (2022)

Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985)

Epidrugs as Promising Tools to Eliminate Plasmodium falciparum Artemisinin-Resistant and Quiescent Parasites
por: Reyser, Thibaud, et al.
Publicado: (2023)

Cell therapy for central nervous system disorders: Current obstacles to progress
por: Yasuhara, Takao, et al.
Publicado: (2019)

Role of Adiponectin in Central Nervous System Disorders
por: Bloemer, Jenna, et al.
Publicado: (2018)

Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
por: Jin, Ye, et al.
Publicado: (2022)

miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach
por: Salvatori, Francesca, et al.
Publicado: (2023)

Regulators of cholinergic signaling in disorders of the central nervous system
por: Winek, Katarzyna, et al.
Publicado: (2021)

Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
por: Pasierski, Michał, et al.
Publicado: (2022)

Nanomedicine-based immunotherapy for central nervous system disorders
por: Hanif, Sumaira, et al.
Publicado: (2020)

Neurometabolic disorders and congenital malformations of the central nervous system
por: BoAli, Ahmed Y., et al.
Publicado: (2018)

Combined modality therapy of central nervous system tumours
por: Rampling, R
Publicado: (2001)

Radiation Therapy for Primary Central Nervous System Lymphoma
por: Shibamoto, Yuta
Publicado: (2013)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder
por: Shuid, Ahmad Naqib, et al.
Publicado: (2020)

Imaging of Central Nervous System Involvement in Pediatric Hematologic Disorders
por: Kalın, Sevinç, et al.
Publicado: (2022)

Inflammatory Disorders of the Central Nervous System Vessels: Narrative Review
por: Ekkert, Aleksandra, et al.
Publicado: (2022)

Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
por: Panchal, Sunil K., et al.
Publicado: (2022)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Mitochondria and Central Nervous System Disorders
por: Knedlik, Tomas, et al.
Publicado: (2022)

The Central Nervous System of Vertebrates
por: Nicholls, J. G.
Publicado: (1967)

Non-Viral Delivery of RNA Gene Therapy to the Central Nervous System
por: Hauck, Ellen S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_535tm6nqh1p7j39hr22r6jtoht